35314 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
 
 
     Nasdaq OMX
 
Rechercher dans le flux Nasdaq GlobeNewswire
Rechercher
Ossur Hf : Transactions in relation to share buyback program
Mon, 30 05 2016 16:00:00
Announcement from Össur hf. No. 59/2016 Reykjavík, 30 May 2016 On 3 December 2015, Össur hf. initiated a share buy-back program, see Company announcement no. 48/2015. The purpose of the share (...)
GUERBET :Nicolas Louvet joins Board of Directors Jean-Jacques Bertrand and Christian Louvet end their term of office
Mon, 30 05 2016 15:45:00
Guerbet: Nicolas Louvet joins Board of Directors Jean-Jacques Bertrand and Christian Louvet end their term of office Villepinte, 30 May 2016 - Guerbet (FR0000032526 GBT), global specialist in contrast agents and (...)
GUERBET :Nicolas Louvet devient administrateur Jean-Jacques Bertrand et Christian Louvet achèvent leur mandat
Mon, 30 05 2016 15:45:00
Guerbet : Nicolas Louvet devient administrateur Jean-Jacques Bertrand et Christian Louvet achèvent leur mandat Villepinte, le 30 mai 2016 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et (...)
Agfa-Gevaert: Publication of a transparency notification - Regulated information
Mon, 30 05 2016 15:40:00
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel , Belgium - May 30, 2016 - 5.40 p.m. CET According to Agfa-Gevaert NV's bylaws, the threshold as from which a (...)
Korrigering: New scheduled Annual General Meeting 20 June
Mon, 30 05 2016 14:29:16
Navamedics Annual General Meeting originally scheduled for May 26 will be held on 20 June. Attached to this notice includes supporting papers identical with the notice of May 26 with the exemption of item 6 - determination of (...)
New scheduled Annual General Meeting 30 June
Mon, 30 05 2016 14:00:00
Navamedics Annual General Meeting originally scheduled for May 26 will be held on 20 June. Attached to this notice includes supporting papers identical with the notice of May 26 with the exemption of item 6 - determination of (...)
Virbac : Mise à disposition des documents préparatoires à l'Assemblée Générale
Mon, 30 05 2016 11:54:49
  VIRBAC ________________ Le 27 mai 2016     COMMUNIQUE PRECISANT LES MODALITES DE MISE A DISPOSITION OU DE CONSULTATION DES DOCUMENTS PREPARATOIRES A (...)
Novo Nordisk A/S - Share repurchase programme
Mon, 30 05 2016 11:27:32
Bagsværd, Denmark, 30 May 2016 - On 3 February 2016, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the (...)
Neovacs to Present at Bio International Convention 2016
Mon, 30 05 2016 06:00:00
  PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs to Present at Bio International Convention 2016 Paris and Boston, May 30 th (...)
Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting
Mon, 30 05 2016 06:00:00
Presentations include positive preclinical toxicology results, quality-of-life data and physician OFF episode treatment practices TORONTO, May 30, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics, Inc. (NASDAQ:CYNA) (TSX:CTH), a (...)
Néovacs participe à la conférence Bio International 2016
Mon, 30 05 2016 06:00:00
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs participe à la conférence Bio International 2016 Paris, Boston, le 30 mai (...)
AB Science Will Present Phase 3 Data in Severe Systemic Mastocytosis at the International 21st Congress of the European Hematology Association
Mon, 30 05 2016 05:47:13
Paris, 30 th of May 2016, 8am AB Science Will Present Phase 3 Data in Severe Systemic Mastocytosis at the International 21 st Congress of the European Hematology Association (EHA) (...)
AB Science présentera les données de l'étude de phase 3 dans la mastocytose systémique sévère au 21eme Congrès international de de l'Association Européenne d'Hématologie
Mon, 30 05 2016 05:47:13
Paris, 30 mai 2016, 8h AB Science présentera les données de l'étude de phase 3 dans la mastocytose systémique sévère au 21eme Congrès international de de l'Association Européenne d'Hématologie (...)
Addex Increases Issued Share Capital and Creates Treasury Shares
Mon, 30 05 2016 05:00:00
Geneva, Switzerland, 30 May 2016 - Addex Therapeutics (SIX: ADXN) announced today that it has increased its capital from 11,699,612 to 13,454,553 through the issue of 1,754,941 new registered shares at nominal value of CHF1 each to Addex (...)
Semaglutide demonstrated superior glycaemic control vs insulin glargine U100 in adults with type 2 diabetes
Fri, 27 05 2016 22:16:22
Read the press release This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely (...)
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Fri, 27 05 2016 19:47:03
COPENHAGEN, Denmark, May 27, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on May 26, 2016 (see company announcement no. 18 / 2016 ), has now been (...)
Annual General Shareholders' Meeting
Fri, 27 05 2016 12:35:52
Irvine, CA, and Herstal, BELGIUM - May 27, 2016 - MDxHealth SA (Euronext: MDXH), held today its Annual General Shareholders' Meeting in Diegem. The shareholders approved all agenda items of the Annual General Shareholders' Meeting, (...)
Assemblée Générale Ordinaire des Actionnaires
Fri, 27 05 2016 12:35:52
Irvine, CA et Herstal, Belgique - Le 27 mai 2016 - MDxHealth SA (Euronext : MDXH), a tenu aujourd'hui son Assemblée Générale Annuelle des Actionnaires à Diegem. Les actionnaires ont approuvé tous les sujets à l'ordre du jour de (...)
Bavarian Nordic A/S - Articles of Association
Fri, 27 05 2016 08:56:08
Updated Articles of Association for Bavarian Nordic A/S. BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. (...)
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Fri, 27 05 2016 08:37:35
COPENHAGEN, Denmark, May 27, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 925,000 as a consequence of employees' exercise of warrants.  (...)
CapMan Buyout sells Esperi
Fri, 27 05 2016 06:30:00
CapMan Plc        Stock Exchange Release                27 May 2016 at 9.30 a.m. EEST CapMan Buyout sells Esperi Funds managed by CapMan have agreed to sell their holdings in Esperi Care Oy. The transaction generates ?6.1 million in (...)
Annual General Meeting of Active Biotech AB
Fri, 27 05 2016 06:30:00
The Annual General Meeting of Active Biotech was held on May 26, 2016. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The board members and the managing director were discharged from (...)
Kommuniké från årsstämma i Xbrane Biopharma AB (publ)
Fri, 27 05 2016 06:00:00
Pressmeddelande 2016-05-27     Aktieägarna i Xbrane Biopharma AB (publ) samlades torsdagen den 26 maj 2016 i Stockholm för årsstämman. Koncernens resultat- och balansräkningar fastställdes och styrelsen och (...)
Xbrane Biopharma AB (publ) publicerar delårsrapport för perioden januari - mars 2016
Fri, 27 05 2016 06:00:00
Pressmeddelande 2016-05-27 Xbrane Biopharma ABs delårsrapport för perioden januari - mars 2016 finns från och med idag tillgänglig på bolagets webbsida, www.xbrane.com . Perioden januari - mars 2016 (...)
Fagron NV: Disclosure of received notifications
Thu, 26 05 2016 21:22:53
Regulated information Waregem (Belgium)/Rotterdam (The Netherlands) 1 , 26 May 2016 Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the following (...)
publicités
publicité
 
  KauriWeb

Afficher toutes les thématiques